Your browser doesn't support javascript.
loading
An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trial.
Leuk Lymphoma ; 56(3): 630-8, 2015 Mar.
Article em En | MEDLINE | ID: mdl-24844361
ABSTRACT
We report long-term results in 40 patients with Philadlephia chromosome-positive (Ph+) acute leukemia who received an imatinib monotherapy window to evaluate in vivo effects on BCR-ABL signaling prior to induction chemotherapy. The first 25 patients (cohort 1) received the LALA-94 protocol without further imatinib (newly diagnosed Ph+ acute lymphoblastic leukemia [ALL]) or induction chemotherapy followed by single-agent imatinib. Subsequent patients (cohort 2) continued imatinib concurrently with either LALA-94 (newly diagnosed Ph + ALL) or other intensive chemotherapy regimens. Cohort 2 had a complete response (CR) rate of 93% and 5-year survival of 69%. For newly diagnosed Ph+ ALL, survival was superior in cohort 2 compared with cohort 1. Toxicity was similar to that expected for chemotherapy alone. Among 10 evaluable patients, rapid loss of phospho-CRKL occurred during the imatinib window in seven patients (all achieved CR) and incomplete inhibition in three patients (none with CR). In summary, a pharmacodynamic window design permitted biomarker assessment of BCR-ABL targeting without compromising clinical outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomo Filadélfia / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores de Proteínas Quinases / Leucemia-Linfoma Linfoblástico de Células Precursoras / Mesilato de Imatinib Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomo Filadélfia / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores de Proteínas Quinases / Leucemia-Linfoma Linfoblástico de Células Precursoras / Mesilato de Imatinib Idioma: En Ano de publicação: 2015 Tipo de documento: Article